Fig. 1From: Patient characteristics and initiation of mineralocorticoid receptor antagonists in patients with chronic kidney disease in routine clinical practice in the US: a retrospective cohort studyStudy design showing the respective (a) CKD and (b) MRA populations CKD chronic kidney disease, MRA mineralocorticoid receptor antagonistBack to article page